News Releases - Tumor immunology

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
    • Filter by program
    About Ludwig Cancer genomics Cancer prevention Tumor biology Tumor immunology Tumor microenvironment
    View All
    Three Ludwig Harvard and MIT researchers elected members of the National Academy of Medicine
    October 22, 2024
    A remote-controlled car for cancer immunotherapy
    October 21, 2024
    Ludwig Lausanne Director George Coukos elected to the National Academy of Medicine
    October 21, 2024
    An AI-powered pipeline for personalized cancer vaccines
    October 11, 2024
    How the scars of demolished brain tumors seed relapse
    September 9, 2024
    A switch for immune memory and anti-tumor immunity
    August 23, 2024
    Two-pronged attack strategy boosts immunotherapy in preclinical studies
    June 3, 2024
    AI predicts tumor-killing cells with high accuracy
    May 7, 2024
    Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
    April 24, 2024
    Immune networks in tumors prime responses to a personalized immunotherapy
    February 6, 2024
    Immunologist Lydia Lynch appointed member of Ludwig Princeton
    January 29, 2024
    How a timekeeping gene affects tumor growth depends entirely on context
    January 24, 2024
    Analysis of brain tumor blood vessels yields a candidate therapy—and a platform to find more
    January 18, 2024
    Five Ludwig Cancer Research scientists elected Fellows of the American Association for Cancer Research
    January 17, 2024
    Ludwig Chicago study uncovers potential drug target to overcome resistance to radiotherapy
    December 15, 2023
    Nutrient in beef and dairy products boosts immune response to cancer
    November 28, 2023
    Ludwig Institute Board Member Jedd Wolchok elected to National Academy of Medicine
    October 13, 2023
    Study shows how brain tumors make certain immune cells turn traitor
    September 27, 2023
    Combination of personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer
    September 21, 2023
    Disrupting a core metabolic process in T cells may improve their therapeutic efficacy
    September 20, 2023
    Ludwig Lausanne study illuminates a potentially exploitable coordination of gene expression across the tumor microenvironment
    August 3, 2023
    Ludwig Cancer Research study shows tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer
    July 10, 2023
    Ludwig Harvard team devises platform to bring “multiplex” imaging to the clinical pathology laboratory
    June 22, 2023
    Ludwig Cancer Research study shows certain blood pressure drugs could boost the efficacy of cancer immunotherapy
    June 7, 2023
    Ludwig Chicago study identifies potentially new strategy for combination radio- and immunotherapy
    May 26, 2023
    Ludwig Lausanne’s Douglas Hanahan elected Foreign Member of the Royal Society
    May 10, 2023
    Two Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
    April 17, 2023
    Ludwig Cancer Research scientists to present at AACR Annual Meeting
    April 17, 2023
    Two Ludwig Cancer Research studies reveal essential role of neutrophils in immunotherapy
    March 30, 2023
    Ludwig Cancer Research study uncovers novel aspect of tumor evolution and potential targets for therapy
    January 5, 2023
    Ludwig Cancer Research study finds common, targetable mechanism tumors use to suppress immune responses
    November 17, 2022
    Ludwig Chicago nanotechnology induces therapeutic immune responses against multiple types of tumors in preclinical studies
    October 27, 2022
    Ludwig Lausanne researchers develop strategy to noninvasively monitor key immune cells in tumors
    October 19, 2022
    Ludwig Oxford’s Yang Shi elected to National Academy of Medicine
    October 17, 2022
    Ludwig Lausanne study identifies potential combination therapy for testing in deadly brain cancer
    September 20, 2022
    Ludwig Oxford Member Yang Shi elected Member of the European Molecular Biology Organization
    July 7, 2022
    Ludwig MSK study modeling tumor evolution reveals a vulnerability for cancer prevention and therapy
    May 11, 2022
    Ludwig Cancer Research scientists to present advances in cancer immunotherapy, metastasis, diagnostics and more at 2022 AACR Annual Meeting
    April 4, 2022
    Four Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
    March 23, 2022
    Ludwig Cancer Research study identifies potential vulnerability in drug-resistant neuroblastoma
    February 7, 2022
    First patient dosed in Phase I/IIa trial of lung cancer immunotherapy vaccine
    January 18, 2022
    Ludwig Lausanne team devises a method to selectively grow tumor-targeting T cells for cancer therapy
    November 15, 2021
    Study led by Ludwig researchers identifies strategy to overcome colorectal cancer resistance to immunotherapy
    November 9, 2021
    Ludwig Cancer Research study identifies cellular interactions essential to the immune attack on ovarian tumors
    November 5, 2021
    Ludwig Lausanne study shows how tumors turn immune cells into enablers of their growth
    October 25, 2021
    Ludwig Lausanne study identifies potential combination therapy for brain metastases of breast cancer
    October 18, 2021
    Ludwig Lausanne Director George Coukos receives 2021 ESMO Translational Research Award
    September 17, 2021
    Ludwig MIT study identifies new targets for cancer vaccines
    September 16, 2021
    Ludwig Lausanne researchers show a little radiation goes a long way in heating up cold tumors
    September 9, 2021
    Study led by Ludwig Oxford researchers shows Oxford COVID vaccine technology can be adapted for cancer vaccines
    September 2, 2021
    Ludwig Cancer Research welcomes Mikaël Pittet to Ludwig Lausanne
    August 4, 2021
    Ludwig Chicago study shows vitamin A derivative enhances tumor-killing effects of radiotherapy
    June 21, 2021
    Ludwig Cancer Research study reveals how certain immune cells in body cavities help suppress anti-tumor immunity
    June 10, 2021
    Ludwig Cancer Research study discovers how to revive potent but inert anti-cancer immune cells for therapy
    May 24, 2021
    Ludwig Cancer Research scientists to present advances in immunotherapy, cancer metabolism, metastasis and detection at first AACR Annual Meeting 2021
    April 10, 2021
    Ludwig Johns Hopkins researchers develop a prototype CAR T cell therapy that targets the loss of a gene copy
    March 19, 2021
    Ludwig Johns Hopkins researchers devise new strategy for cancer immunotherapy
    March 1, 2021
    Ludwig Cancer Research study uncovers metabolic vulnerability in suppressive immune cells that may be targeted for cancer immunotherapy
    February 15, 2021
    Ludwig Cancer Research study reveals how certain gut bacteria compromise radiotherapy
    January 26, 2021
    Ludwig Lausanne receives Team Science Award from the Society for Immunotherapy of Cancer
    November 14, 2020
    A better test for the tumor-targeting of CAR-T therapies
    November 6, 2020
    Ludwig study finds a common nutritional supplement might boost the effects of cancer immunotherapy
    October 5, 2020
    Toward a personalized cancer nanovaccine
    October 2, 2020
    Ludwig Lausanne’s Ping-Chih Ho named Lloyd J. Old STAR researcher
    August 5, 2020
    Ludwig Cancer Research study finds reprogramming of immune cells enhances effects of radiotherapy in preclinical models of brain cancer
    July 15, 2020
    Juanita L. Merchant appointed to the Ludwig Institute’s Scientific Advisory Committee
    July 14, 2020
    Epigenetics researcher Yang Shi appointed Member of Ludwig Oxford
    July 1, 2020
    Ludwig Lausanne study charts the immune landscape of multiple brain cancers
    May 28, 2020
    Ludwig Johns Hopkins researchers to clinically evaluate use of blood pressure drug to prevent serious complication of COVID-19
    May 22, 2020
    Ludwig MSK study reveals bile metabolite of gut microbes boosts immune cells that can help contain cancer-driving inflammation
    April 15, 2020
    Targeting turncoat immune cells to treat cancer
    February 17, 2020
    Dismantling drug resistance in colorectal cancer
    February 5, 2020
    Building a safer CAR-T therapy
    February 3, 2020
    Robert Schreiber joins the Ludwig Institute’s Scientific Advisory Committee
    January 31, 2020
    Douglas Hanahan appointed Distinguished Scholar of the Ludwig Institute for Cancer Research
    January 14, 2020
    Ping-Chih Ho appointed Associate Member of Ludwig Institute for Cancer Research
    January 9, 2020
    Vaccitech Oncology Limited and the Ludwig Institute for Cancer Research enter collaboration with Cancer Research UK for Phase I/IIa clinical trial as first-line NSCLC therapy
    December 18, 2019
    Ludwig researchers engineer CAR-T cells to resist exhaustion, attack solid tumors in mice
    December 10, 2019
    Ludwig Lausanne’s Ping-Chih Ho named an EMBO Young Investigator
    November 13, 2019
    Ludwig researchers develop machine learning tool to refine personalized immunotherapy
    October 14, 2019
    Ludwig Cancer Research congratulates Bert Vogelstein and Irv Weissman, winners of the 2019 Albany Medical Center Prize in Medicine and Biomedical Research
    August 20, 2019
    New ‘don’t eat me’ signal may provide basis for cancer therapies
    July 31, 2019
    Molecular chatter makes for a “hot tumor”
    June 10, 2019
    Ludwig Harvard study finds that combining blood pressure drug with checkpoint blockade could boost cancer immunotherapies
    May 1, 2019
    Modified immune cells issue alert when detecting cancer in mice
    March 19, 2019
    An atlas of an aggressive leukemia
    February 28, 2019
    Utilizing molecular imaging technologies to predict, monitor and optimize immunotherapies
    February 20, 2019
    Heating up cold tumors
    January 21, 2019
    Strategies to investigate and target the tumor microenvironment
    October 20, 2018
    Johanna Joyce appointed Member of Ludwig Institute for Cancer Research, Lausanne
    October 4, 2018
    A “non-canonical” strategy may improve cancer radiotherapy
    August 29, 2018
    Ludwig Cancer Research and Cancer Research Institute launch clinical trial combining virotherapy and immunotherapy to treat advanced colorectal and ovarian cancers
    July 11, 2018
    ASCO to honor Ludwig scientists at 2018 annual meeting
    May 30, 2018
    Engineered T cell therapy clears incurable childhood brain tumor in mice
    April 20, 2018
    Ludwig researchers devise and test pioneering personalized cancer vaccine for ovarian cancer
    April 11, 2018
    Ludwig scientists share new findings on personalized cancer treatments, immunotherapy and the tumor microenvironment at 2018 AACR annual meeting
    April 11, 2018
    Ludwig study extends the potential for personalized immunotherapy to a large variety of cancers
    March 15, 2018
    Ludwig researchers devise and test novel combination therapy for advanced melanoma
    January 29, 2018
    Ludwig Stanford researchers discover second “don’t eat me” signal on cancer cells
    November 27, 2017
    Ludwig researchers unravel novel mechanism by which tumors grow resistant to radiotherapy
    November 23, 2017
    Ludwig researchers uncover novel mechanism by which tumors evade a variety of cancer immunotherapies
    November 10, 2017
    Why some people with pancreatic cancer live longer than others
    November 9, 2017
    Ludwig scientists share insights on immunotherapy research at the 2017 Society for Immunotherapy of Cancer annual meeting
    November 6, 2017
    Ludwig presence at 2017 Society for Immunotherapy of Cancer Annual Meeting
    November 6, 2017
    Ludwig scientists discover complex axis of immune suppression exploited by cancers
    September 19, 2017
    Ludwig scientists shared data on clinical and other studies at 2017 International Cancer Immunotherapy Conference
    September 11, 2017
    Johanna Joyce elected to EMBO
    June 16, 2017
    Growing evidence that flaws in a tumor’s genetic mending kit drives response to immunotherapy
    June 8, 2017
    Ludwig researchers present new findings on combination immunotherapy and other research at the 2017 ASCO Annual Meeting
    May 31, 2017
    Ludwig presence at 2017 ASCO annual meeting
    May 30, 2017
    Ludwig researchers find breakthrough cancer therapy may work in an unexpected way
    May 17, 2017
    Ludwig scientists reveal new advances in immunotherapy, predictive biomarkers and overcoming treatment resistance at 2017 AACR annual meeting
    March 29, 2017
    Ludwig congratulates Thierry Boon on receiving the ITOC Lifetime Achievement Award
    March 21, 2017
    Ludwig Stanford researchers show ‘don’t eat me’ antibody could help treat pediatric brain tumors
    March 20, 2017
    New technique reveals movements of immune cells as they hunt for tumors in living patients
    January 23, 2017
    Ludwig study reveals why cancer cells spread within the body
    January 16, 2017
    New immunotherapy possible for canine cancer
    November 15, 2016
    Ludwig researchers show how a targeted drug overcomes suppressive immune cells
    November 9, 2016
    Ludwig study exposes key requirement for regulatory T cell function
    September 22, 2016
    Ludwig researchers discover how cancer cells gum up the trigger of a T cell attack
    July 26, 2016
    Radiation and vaccination can magnify effects of immunotherapy
    June 14, 2016
    Ludwig researchers showcase new findings on immunotherapy, liquid biopsies and other aspects of cancer care at the 2016 Annual Meeting of the American Society of Clinical Oncology
    June 2, 2016
    Ludwig Presence at 2016 ASCO annual meeting
    June 2, 2016
    George Demetri on sarcoma
    April 27, 2016
    Longest follow-up of survival after treatment with nivolumab reported at AACR Annual Meeting 2016
    April 17, 2016
    Ludwig researchers showcase new findings on immunotherapy, liquid biopsies and other aspects of cancer care at the 2016 Annual Meeting of the American Society of Clinical Oncology
    April 12, 2016
    Ludwig presence at the 2016 AACR annual meeting
    April 12, 2016
    Ludwig Cancer Research and the Cancer Research Institute initiate clinical trial of a novel combination immunotherapy for ovarian cancer
    April 6, 2016
    Ludwig scientists named to Thomson Reuters’ list of world’s most influential scientific minds
    February 18, 2016
    Ludwig Cancer Research and Cancer Research Institute partner with Targovax to test candidate virotherapy in early-phase clinical trials
    November 18, 2015
    Ludwig MSK director Alexander Rudensky elected to National Academy of Medicine
    October 19, 2015
    Immunomodulation of the tumor microenvironment
    October 16, 2015
    Pathways to Carcinogenesis: Stem cells, progression and the rogue cell’s ‘Don’t eat me’ signal​​
    September 23, 2015
    Ludwig Cancer Research and University of Oxford launch cancer immunotherapy spinout
    July 9, 2015
    Ludwig Cancer Research and the Cancer Research Institute evaluate immunotherapeutic strategies for brain cancer and other types of solid tumors
    July 8, 2015
    Press conference remarks for launch of the Ludwig Lausanne Branch
    June 11, 2015
    Ludwig Cancer Research expands presence in Lausanne
    June 11, 2015
    Phase 3 trial led by Ludwig researchers confirms power of combination immunotherapy for advanced melanoma
    May 31, 2015
    Phase 2 trial identifies genetic dysfunction that makes many types of cancer vulnerable to an immunotherapy
    May 29, 2015
    Ludwig presence at Ludwig scientists to report advances in treatment of brain, skin, gastrointestinal cancers at 2015 ASCO annual meeting
    May 26, 2015
    Ludwig presence at 2015 ASCO annual meeting
    May 22, 2015
    Immunotherapy combination promising for untreated patients with advanced melanoma
    April 20, 2015
    Ludwig scientists to present advancements in immunotherapy, diagnostics, cell biology and genomics at 2015 AACR annual meeting
    April 14, 2015
    Ludwig presence at 2015 AACR annual meeting
    April 13, 2015
    Ludwig Cancer Research and Conrad N. Hilton Foundation partner to advance dietary prevention and early detection of colon cancer
    February 11, 2015
    Agenus and Ludwig sign agreement for further development of novel immunotherapies
    December 11, 2014
    The STING of radiation
    November 20, 2014
    A signature for success
    November 19, 2014
    Ludwig Oxford’s Mads Gyrd-Hansen named an EMBO Young Investigator
    November 12, 2014
    Ludwig Cancer Research and Cancer Research Institute collaborate on evaluation of VentiRx’s investigational immunotherapy
    September 3, 2014
    Immune system vs. cancer
    July 21, 2014
    Ludwig researchers target two types of pancreatic cancer
    May 20, 2014
    Two Ludwig researchers to give plenary presentations on immunotherapy at 2014 AACR annual meeting
    April 6, 2014
    Five Ludwig researchers named AACR fellows
    April 2, 2014
    Ludwig scientists to present advancements in immunotherapy, genomics and metastasis at 2014 AACR annual meeting
    April 2, 2014
    Ludwig presence at 2014 AACR annual meeting
    April 2, 2014
    Ludwig and Agenus to advance three checkpoint modulator antibodies into development
    March 5, 2014
    Going viral to target tumors
    March 5, 2014
    Ludwig’s Jedd Wolchok honored with AACR-Rosenthal Foundation Memorial Award
    March 4, 2014
    Ludwig Cancer Research bestows half a billion in new funding to six eminent U.S. research institutions
    January 6, 2014
    Ludwig Center directors comment on the impact of the $540 million gift from Ludwig Cancer Research
    January 6, 2014
    Novel blood test for predicting response to cancer therapy to be commercialized by Ludwig start-up Serametrix Corporation
    December 9, 2013
    CureVac collaborates with the Cancer Research Institute and Ludwig Cancer Research to enable clinical testing of novel immunotherapy treatment options for cancer
    November 5, 2013
    Ludwig scientists at Johns Hopkins find promising therapeutic target for hard-to-treat brain tumor
    August 27, 2013
    Immune Design partners with leading cancer organizations to advance novel immunotherapy research
    June 12, 2013
    Concurrent treatment with two antibodies that boost the immune response to tumors in distinct ways appears to be highly effective against metastatic melanoma
    June 2, 2013
    Anti-CD47 antibody may offer new route to a successful cancer vaccination
    May 31, 2013
    Engineered molecules boost immune attack on cancer
    May 31, 2013
    Ludwig presents advancements in immunotherapy and epigenetics at AACR meeting
    April 10, 2013
    4-Antibody AG and the Ludwig Institute expand oncology antibody R&D program with three new
    January 29, 2013
    Mouse model exposes a new type of T cell to target melanoma
    October 24, 2012
    MedImmune joins forces with leading cancer organizations to advance novel immunotherapy research
    October 9, 2012
    Immune responses can be generated locally within human melanoma skin metastases
    July 31, 2012
    Ludwig welcomes the appointment of George Coukos to new European cancer center of excellence
    July 3, 2012
    The Ludwig Institute for Cancer Research highlights more than a dozen abstracts at the annual meeting of the American Society of Clinical Oncology
    June 1, 2012
    The Ludwig Institute for Cancer Research announces launch of Iteos Therapeutics SA
    May 3, 2012
    Single antibody shrinks variety of human tumors transplanted into mice, study by Ludwig Center Director Irv Weissman shows
    March 27, 2012
    Woman’s recovery from advanced melanoma could help guide research
    March 9, 2012
    New England Journal of Medicine study shows pairing immunotherapy with radiotherapy improves a patient’s ability to fight melanoma
    March 7, 2012
    Antibodies to elusive intracellular cancer antigens combined with chemotherapy enhance anti-cancer immunity, scientists report
    February 13, 2012
    New target for cancer therapy identified, preclinical study shows
    January 30, 2012
    Novel cancer treatment combination receives approval to begin first-in-human testing for patients with advanced metastatic melanoma
    December 8, 2011
    A tribute to Dr. Lloyd Old
    November 29, 2011
       Back to News

    Stay In Touch

    Notice
    ?

    You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?

    Continue
    Cancel